期刊文献+

IL-6与慢性阻塞性肺疾病关系的研究进展 被引量:18

Research Progress in Relationship between Interleukin-6 and Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 慢性阻塞性肺疾病(COPD)是一种炎症介导的以气道重塑和肺实质破坏为特征的疾病。长期吸烟、呼吸道频繁感染、气道反应性增高等因素导致多种炎性细胞和细胞因子在呼吸道和(或)肺内活化、聚集、浸润炎症部位,释放各种炎性介质,导致气道和(或)肺实质结构和功能异常。其中,对白细胞介素6(IL-6)的研究较为成熟,IL-6主要由单核巨噬细胞、血管内皮细胞、辅助性T细胞等多种细胞产生,具有复杂的生物效能,对COPD的炎症过程有重要意义,并与COPD的发病机制密切相关。 Chronic obstructive pulmonary disease(COPD)is a disease characterized by inflammation-mediated airway remodeling and lung parenchymal destruction.Long-term smoking,recurrent respiratory infections and airway hyper-responsiveness,etc.cause a variety of inflammatory cells and cell factors to activate,aggregate and infiltrate in the inflammation sites of the airway and/or lung,thereby releasing various inflammatory mediators,leading to changes in the airway and/or lung structure and function.Among them,the study of interleukin-6(IL-6)is relatively mature.IL-6 is mainly secreted by monocytes,macrophages,vascular endothelial cells,helper T cells and other cells.It has a complex biological role and is important for the inflammatory process of COPD,and is closely related to the pathogenesis of COPD.
作者 潘美妮 罗维贵 李林霖 曾叔兵 潘新梅 PAN Meini;LUO Weigui;LI Linlin;ZENG Shubing;PAN Xinmei(Graduate School of Youjiang Medical College for Nationalities,Baise 533000,China;Department of Respiratory Medicine,Affiliated Hospital of Youjiang Medical University for Nationalities,Baise 533000,China)
出处 《医学综述》 2018年第24期4796-4801,4807,共7页 Medical Recapitulate
基金 医学科学研究基金资助项目(YWJKJJHKYJJB184044) 百色市科学研究与技术开发计划项目(百科计20110509)
关键词 慢性阻塞性肺疾病 白细胞介素6 细胞因子 Chronic obstructive pulmonary disease Interleukin-6 Cell factor
  • 相关文献

参考文献4

二级参考文献25

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2039
  • 2张旭东.呼出气冷凝液检测炎性指标监测在慢性阻塞性肺疾病患者中的临床应用[J].中国老年学杂志,2014,34(11):2988-2990. 被引量:12
  • 3JONES PW, HARDING G,BERRY P,et al.Development and first vali-dation of the COPD assessment test [J].Eur Respir J,2009,34:648-654.
  • 4MATSUURA H,HARTL D,KANG MJ,et al.Role of breast regression protein -39 in the pathogenesis of cigarette smoke -induced inflammation and emphysema[J].Am J Respir Cell Mol Biol,2011,44(6):777-786.
  • 5LOMAS DA,SILVERMAN EK,EDWAKDS LD,et al.Evaluation of serum CC16 as a biomarker for COPD in the ECLIPSE cohort[J].Thorax,2008,63(12):1058-1063.
  • 6KUNZ LI,LAPPERRE TS,SNOECK-STHOBAND JB,et al.Smoking status and anti -inflammatory macrophages in bronchoalveolar lavage andinduced sputum in COPD[J].Respir Res,2011,l2:34.
  • 7SIN DD,LEUNG R,GAN WQ,et al.Circulating surfactant protein D as a potential lung -specific biomarker of health outcomes in COPD: a pilot study [J].BMC Pulm Med,2007,7:13.
  • 8HE ZH,CHEN P,CHEN Y,et al.Comparison between cigarette smoke -induced emphysema and cigarette smoke extract - induced emphysema[J].Tob Indue Dis,2015,13(1);6.
  • 9DIMA E,KOLTSIDA O,KATSAOUNOU P,et al.Implication of Interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD)[J].Cytokine,2015,25.
  • 10LAUCHO-CONTRERAS ME,POLVERINO F,GUPTA K,et al.Protective role for club cell secretory protein-16(CC16) in the development of chronic obstructive pulmonary disease [J].Eur Respir J,2015,19.

共引文献86

同被引文献257

引证文献18

二级引证文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部